Dose of Metoprolol CR/XL and clinical outcomes in patients with heart failure: Analysis of the experience in Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF)

We performed a post-hoc subgroup analysis in the Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF) with the aim of reporting on the heart rate (HR) response during the titration phase and clinical outcomes from the three-month follow-up visit to end of study in two d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2002-08, Vol.40 (3), p.491-498
Hauptverfasser:	WIKSTRAND, John, HJALMARSON, Ake, WAAGSTEIN, Finn, FAGERBERG, Björn, GOLDSTEIN, Sidney, KJEKSHUS, John, WEDEL, Hans
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - administration & dosage Adrenergic beta-Antagonists - blood Aged Beta blockers Biological and medical sciences Blood pressure Cardiology Cardiovascular system Chronic Disease Clinical outcomes Confidence intervals Dose-Response Relationship, Drug Drug therapy Female Follow-Up Studies Heart attacks Heart failure Heart Failure - complications Heart Failure - drug therapy Heart Failure - mortality Heart rate Heart Rate - drug effects Humans Incidence Male Medical sciences Medicine Metoprolol - administration & dosage Metoprolol - analogs & derivatives Metoprolol - blood Middle Aged Mortality Myocardial Infarction - complications Myocardial Infarction - drug therapy Myocardial Infarction - mortality Pharmacology. Drug treatments Statistical methods Survival Analysis Time Factors Treatment Outcome Vasodilator agents. Cerebral vasodilators Withholding Treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!